|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.25 GBX | +3.75% |
|
-0.57% | +2.54% |
| 06-02 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 | |
| 05-26 | Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 2.61x | - | 2.11x | 9.6x | 31.06x | -.--% | 142M | |
| -79.42x | 7.22x | 0.22x | 17.38x | 43.2x | -70.28x | -.--% | 43.45B | |
| 29.39x | 3.11x | 0.42x | 2.18x | 18.83x | 31.93x | 1.62% | 3.2B | |
| 89.36x | 5.8x | 1.29x | 11.48x | 17.89x | 106.25x | 0.29% | 3.05B | |
| 36.16x | 13.23x | 2.31x | 11.65x | 25.2x | 28.87x | 1.89% | 2.08B | |
| -75.63x | 3.78x | 0.89x | - | - | - | 0.1% | 1.28B | |
| 28.51x | 2.34x | 3.23x | 3.81x | 15.44x | 20.08x | 0.63% | 1.28B | |
| 39.6x | 8.02x | 1.24x | 16.33x | 25.34x | 27.81x | 0.58% | 1.17B | |
| 13.7x | 4.04x | 0.35x | - | - | - | 0.42% | 1.02B | |
| -1.42x | - | 0.18x | 4.97x | 8.12x | 93.86x | -.--% | 386M | |
| 25.07x | 3.17x | 1.49x | 2.74x | 8.09x | 12.89x | - | 161M | |
| -60.5x | 4.93x | 0.67x | 1.66x | 12.81x | -42.05x | - | 133M | |
| Average | 4.08x | 5.30x | 1.12x | 7.43x | 18.45x | 24.04x | 0.55% | 4.78B | |
| Weighted average by Cap. | -52.68x | 6.88x | 0.48x | 15.41x | 38.17x | -44.91x | 0.21% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
